Companies:

 

Articles:

 

Stock summary

Companies:

 

Race Oncology Ltd (ASX: RAC)

 
Service provided by WebLinkIR

Company videos

Company news

Cover Image for Race Oncology heads into 2022 with extra $29.7m in bank to advance lead drug Zantrene

Race Oncology heads into 2022 with extra $29.7m in bank to advance lead drug Zantrene

Cover Image for Published study highlights ‘superior efficacy’ of Race Oncology’s Zantrene combined with other cancer drugs

Published study highlights ‘superior efficacy’ of Race Oncology’s Zantrene combined with other cancer drugs

Cover Image for Race Oncology confirms lead drug Zantrene has cardio-protective properties during cancer treatment

Race Oncology confirms lead drug Zantrene has cardio-protective properties during cancer treatment

Cover Image for Race Oncology expands Zantrene heart-protective research with University of Newcastle

Race Oncology expands Zantrene heart-protective research with University of Newcastle